Presentation will include results of BTS drug study for BNCT and details about new Fc-engineered antibodies for site-specific conjugation SAN FRANCISCO, Dec. 27, 2023 /PRNewswire/ — At the forefront of pioneering advancements in the field of radiation oncology, TAE Life Sciences is set…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.